Please login to the form below

Not currently logged in
Email:
Password:

New accounts: September

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period June to August 2005 inclusive

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period June to August 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

Allergan

Botox

Neurology

Jango

Chiron Biopharma Europe

N/A

N/A

Woolley Pau

Galderma

New product

Dermatology

Life

Janssen-Cilag

Lyrinel XL

Urinary incontinence

PBC Communications

Link Pharmaceuticals

Gliadel implant

Oncology

Addjuice

Napp Pharmaceuticals

New product

Analgesia

Langland

Pfizer

New product

Ophthalmology

The Medical Multimedia Company

Roche Diagnostics

Cobas

Hospital in-vitro diagnostics

PBC Communications

Roche

New product

Oncology

MJL

Royal Free Hospital

Fundraising

HIV/HCV/HBV

MJL

Royal Numico (global)

Cubitan

Woundcare nutrition

central

Royal Numico (global)

Cubison

Woundcare nutrition

central

Strakan

Rectogesic

Anal fissures

VB Communications

2nd September 2008

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
ApotheCom

ApotheCom is the medical communications division of Huntsworth Health, which is a global family of best-in-class agencies that provide a...

Latest intelligence

Online Physician Communities
M3 improves personalisation of pharma engagement with doctors
Launches new messaging service on Doctors.net.uk...
Digital Futures 2014 slide deck
Full slides, including survey data, from PMLiVE's digital pharma marketing online event...
The Chinese diabetes challenge
Marketing, communications and commercial relationships in China are full of pitfalls for the unwary, but not without great potential ...